This grant's deadline has passed. It may reopen in a future call cycle.
KWF
Lead4Life PPP Call — Lead-212 Radiopharmaceuticals
Call opens 5 May 2026; submission deadline not yet specified
Last verified:
Details
| Funder | KWF |
| Budget | €500k–€2M per project; total €5M |
| Consortium | Required — public-private partnership (PPP) collaboration required |
| Application | Single stage (open competitive selection via KWF GMS) |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
PPP call for projects strengthening Pb-212 production/supply chain or enabling technologies for clinical application of Pb-212-based radiopharmaceuticals. Proposals must involve public-private collaboration and be submitted through KWF GMS; projects are embedded in a national TRT innovation network. Clinical trials and full therapeutic product development are out of scope.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
INTER-LOCAL: International Funding Call for Clinical Research on Local Treatment Strategies
Deadline: 18 Jun 2026Up to €3MBOOST (Bridging Obstacles for Optimal model use via Shared Technical expertise)
Deadline: 1 Jul 2026~€150,000 per projectBoost-2026
Deadline: 7 Jul 2026KWF Pipeline Call 2026
Deadline: 7 Jul 2026€1M-€5MPipeline
Deadline: 7 Jul 2026€1–5M
Browse Related
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free